1. Home
  2. PT vs AYTU Comparison

PT vs AYTU Comparison

Compare PT & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pintec Technology Holdings Limited

PT

Pintec Technology Holdings Limited

HOLD

Current Price

$0.92

Market Cap

14.7M

Sector

Technology

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.57

Market Cap

23.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PT
AYTU
Founded
2012
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
23.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
PT
AYTU
Price
$0.92
$2.57
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
67.7K
98.6K
Earning Date
09-19-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,961,892.00
$63,696,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$47.32
P/E Ratio
N/A
N/A
Revenue Growth
9.20
N/A
52 Week Low
$0.76
$0.95
52 Week High
$1.38
$2.82

Technical Indicators

Market Signals
Indicator
PT
AYTU
Relative Strength Index (RSI) 40.28 64.74
Support Level $0.92 $2.42
Resistance Level $0.99 $2.59
Average True Range (ATR) 0.05 0.15
MACD -0.01 0.01
Stochastic Oscillator 13.48 87.50

Price Performance

Historical Comparison
PT
AYTU

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: